EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

When pharmacogenomics meets primary care reality

Elisa J Houwink

The Lancet Primary Care · 2026-06 · 2 (6) · 100163

DOI: 10.1016/j.lanprc.2026.100163 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Lancet Primary Care, 2026-06. Verfasst von Elisa J Houwink. Die Arbeit nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pharmacogenomic testing is often promoted as a means to improve the effectiveness and safety of antidepressant prescribing, yet its role in routine primary care remains uncertain. In The Lancet Primary Care, Jon D Emery and colleagues report the PhaRmacogEnomicS In DEpression (PRESIDE) trial, a large, pragmatic, double-blind, randomised controlled trial conducted in an Australian general practice population to evaluate whether pharmacogenomics-guided antidepressant prescribing improves outcomes for adults with moderate to severe depressive symptoms.

Zitieren

APA

Houwink, E. J. (2026). When pharmacogenomics meets primary care reality. The Lancet Primary Care, 2(6), 100163. https://doi.org/10.1016/j.lanprc.2026.100163

Vancouver

Houwink EJ. When pharmacogenomics meets primary care reality. The Lancet Primary Care. 2026;2(6):100163. doi:10.1016/j.lanprc.2026.100163

BibTeX
@article{Houwink2026,
  author = {Houwink, Elisa J},
  title = {When pharmacogenomics meets primary care reality},
  journal = {The Lancet Primary Care},
  year = {2026},
  volume = {2},
  number = {6},
  pages = {100163},
  doi = {10.1016/j.lanprc.2026.100163}
}
Kostenlos starten →